Cargando…
Improved Biodistribution and Extended Serum Half-Life of a Bacteriophage Endolysin by Albumin Binding Domain Fusion
The increasing number of multidrug-resistant bacteria intensifies the need to develop new antimicrobial agents. Endolysins are bacteriophage-derived enzymes that degrade the bacterial cell wall and hold promise as a new class of highly specific and versatile antimicrobials. One major limitation to t...
Autores principales: | Seijsing, Johan, Sobieraj, Anna M., Keller, Nadia, Shen, Yang, Zinkernagel, Annelies S., Loessner, Martin J., Schmelcher, Mathias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277698/ https://www.ncbi.nlm.nih.gov/pubmed/30538696 http://dx.doi.org/10.3389/fmicb.2018.02927 |
Ejemplares similares
-
Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity
por: Schmelcher, Mathias, et al.
Publicado: (2011) -
Synergistic Removal of Static and Dynamic Staphylococcus aureus Biofilms by Combined Treatment with a Bacteriophage Endolysin and a Polysaccharide Depolymerase
por: Olsen, Nanna M. C., et al.
Publicado: (2018) -
Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic Staphylococcus aureus Infection
por: Sobieraj, Anna M., et al.
Publicado: (2020) -
A bacteriophage endolysin that eliminates intracellular streptococci
por: Shen, Yang, et al.
Publicado: (2016) -
Extending the Serum Half-Life of G-CSF via Fusion with the Domain III of Human Serum Albumin
por: Zhao, Shuqiang, et al.
Publicado: (2013)